...
YDESMICRO

YD Bio Limited Ordinary Shares

HealthcareBiotechnology
$8.45
$0.00(-2.87%)
52W$5.30
$25.00
FinancialsValuationvs CAI
Updated Mar 5, 12:00 AM
RSI37
RS Rating19/99
Beta1.64
Volatility192%
F-Score3/9
Mkt Cap$35M
DOWNTREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

DOWNTREND

YD Bio Limited Ordinary Shares is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 19), showing significant lag compared to the market leaders. Earnings contraction of 116% provides fundamental context to the price action. Investors should exercise caution due to high volatility (192% annualized), which requires wider risk management.

Relative Strength
19
out of 99
Lagging
Trend Score
0/4
Minervini Criteria
DOWNTREND
Risk (Beta)
1.64
vs S&P 500
HIGH BETA
52W Position
16%
from 52W low
Near Low
Trend & Momentum Analysis

Trend Template (Minervini)

DOWNTREND0/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$10.94
50 SMA > 100 SMA$12.04
100 SMA > 150 SMA$—
150 SMA > 200 SMA$—

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$9.41-10.24%BELOW
50 SMA$10.94-22.76%BELOW
100 SMA$12.04-29.80%BELOW
150 SMA$——
200 SMA$——

Price Performance

1D-2.9%
1W-6.4%
1M-21.5%
3M-39.2%
6M-45.8%
YTD-29.6%
1Y-29.8%
3Y-11.1%
52-Week Trading Range16% from low
$8.45
52W Low$5.30
52W High$25.00

Technical Indicators

RSI (14)BEARISH
36.9
305070
VCP Score—
—/10
Base depth: —%

Risk Profile

Beta
1.64
52W Vol
192%
ATR
$0.74
Max DD (1Y)
-65%

Volume Analysis

Today
8.3K
50D Avg
40.2K
Vol Ratio
0.21x
Liquidity
ILLIQUID

Earnings Momentum

Q3'24—
$0.54
Q4'24-37%
$0.10
Q1'25+81%
$-0.98
Q2'25-116%
$-0.65
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:—
5 Years:—
3 Years:—
TTM:—

Compounded Profit Growth

10 Years:—
5 Years:—
3 Years:—
TTM:—

Stock Price CAGR

10 Years:-3.48%
5 Years:-6.84%
3 Years:-11.13%
1 Year:-29.82%

Return on Equity

10Y Avg:-6.1%
5Y Avg:-6.1%
3Y Avg:-12.0%
Last Year:-42.7%

Key Metrics

Market Cap$35M
Gross Margin30.4%
Net Margin-2.8%
Piotroski F-Score3/9

More YDES Analysis

Full Financial AnalysisDCF & Intrinsic ValueTotal Return Calculator

Compare With

YDES vs CAICAIVCYTADPTNAUT

Data Dictionary

RS Rating (Relative Strength)

Measures 12-month price performance vs all stocks. Rating of 19 meansYDES outperformed 19% of all stocks. Scores >80 indicate market leaders.

Beta

Measures volatility vs S&P 500. Beta of 1.64 means 64% more volatile than market.

Piotroski F-Score

9-point financial strength score based on profitability, leverage, and efficiency. Score of 3/9. Scores 7-9 = strong, 4-6 average, 0-3 = weak.

VCP (Volatility Contraction Pattern)

Measures base formation quality. Higher scores indicate tighter consolidation near pivot points. Score of N/A/10 with N/A status.

Frequently Asked Questions

Is YDES in an uptrend right now?

YDES has a trend score of 0/4 based on Minervini's Stage Analysis. Currently showing broken structure - 0 of 4 trend criteria are met.

Is YDES overbought or oversold?

YDES's RSI (14) is 37. The stock is in neutral territory, neither overbought nor oversold.

Is YDES outperforming the market?

YDES has a Relative Strength (RS) Rating of 19 out of 99. YDES is currently lagging the broader market.

Where is YDES in its 52-week range?

YDES is trading at $8.45, which is 34% of its 52-week high ($25.00) and 16% above its 52-week low ($5.30).

How volatile is YDES?

YDES has a Beta of 1.64 and 52-week volatility of 192%. It's more volatile than the S&P 500 - expect bigger swings.